Report Detail

Service & Software Global Tumor Models Market Growth (Status and Outlook) 2023-2029

  • RnM4532520
  • |
  • 24 May, 2023
  • |
  • Global
  • |
  • 104 Pages
  • |
  • LPI(LP Information)
  • |
  • Service & Software

The global Tumor Models market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Tumor Models is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Tumor Models is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Tumor Models is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Tumor Models players cover Inotiv, Charles River, WuXi Biology, Labcorp, IITRI, InSphero, Biomodels, Reaction Biology and Oncodesign Services, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “Tumor Models Industry Forecast” looks at past sales and reviews total world Tumor Models sales in 2022, providing a comprehensive analysis by region and market sector of projected Tumor Models sales for 2023 through 2029. With Tumor Models sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor Models industry.

This Insight Report provides a comprehensive analysis of the global Tumor Models landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tumor Models portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tumor Models market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor Models and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor Models.

This report presents a comprehensive overview, market shares, and growth opportunities of Tumor Models market by product type, application, key players and key regions and countries.

Market Segmentation:
Segmentation by type
Cell Line-derived Xenograft (CDX) Tumor Models
Patient-derived Xenograft (PDX) Tumor Models
Syngeneic Tumor Models
Others

Segmentation by application
Clinical Trials
Academic Research
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Inotiv
Charles River
WuXi Biology
Labcorp
IITRI
InSphero
Biomodels
Reaction Biology
Oncodesign Services
Creative Biolabs
Abnova
Invivocue


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Tumor Models Market Size 2018-2029
    • 2.1.2 Tumor Models Market Size CAGR by Region 2018 VS 2022 VS 2029
  • 2.2 Tumor Models Segment by Type
    • 2.2.1 Cell Line-derived Xenograft (CDX) Tumor Models
    • 2.2.2 Patient-derived Xenograft (PDX) Tumor Models
    • 2.2.3 Syngeneic Tumor Models
    • 2.2.4 Others
  • 2.3 Tumor Models Market Size by Type
    • 2.3.1 Tumor Models Market Size CAGR by Type (2018 VS 2022 VS 2029)
    • 2.3.2 Global Tumor Models Market Size Market Share by Type (2018-2023)
  • 2.4 Tumor Models Segment by Application
    • 2.4.1 Clinical Trials
    • 2.4.2 Academic Research
    • 2.4.3 Others
  • 2.5 Tumor Models Market Size by Application
    • 2.5.1 Tumor Models Market Size CAGR by Application (2018 VS 2022 VS 2029)
    • 2.5.2 Global Tumor Models Market Size Market Share by Application (2018-2023)

3 Tumor Models Market Size by Player

  • 3.1 Tumor Models Market Size Market Share by Players
    • 3.1.1 Global Tumor Models Revenue by Players (2018-2023)
    • 3.1.2 Global Tumor Models Revenue Market Share by Players (2018-2023)
  • 3.2 Global Tumor Models Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Tumor Models by Regions

  • 4.1 Tumor Models Market Size by Regions (2018-2023)
  • 4.2 Americas Tumor Models Market Size Growth (2018-2023)
  • 4.3 APAC Tumor Models Market Size Growth (2018-2023)
  • 4.4 Europe Tumor Models Market Size Growth (2018-2023)
  • 4.5 Middle East & Africa Tumor Models Market Size Growth (2018-2023)

5 Americas

  • 5.1 Americas Tumor Models Market Size by Country (2018-2023)
  • 5.2 Americas Tumor Models Market Size by Type (2018-2023)
  • 5.3 Americas Tumor Models Market Size by Application (2018-2023)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Tumor Models Market Size by Region (2018-2023)
  • 6.2 APAC Tumor Models Market Size by Type (2018-2023)
  • 6.3 APAC Tumor Models Market Size by Application (2018-2023)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Tumor Models by Country (2018-2023)
  • 7.2 Europe Tumor Models Market Size by Type (2018-2023)
  • 7.3 Europe Tumor Models Market Size by Application (2018-2023)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Tumor Models by Region (2018-2023)
  • 8.2 Middle East & Africa Tumor Models Market Size by Type (2018-2023)
  • 8.3 Middle East & Africa Tumor Models Market Size by Application (2018-2023)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Tumor Models Market Forecast

  • 10.1 Global Tumor Models Forecast by Regions (2024-2029)
    • 10.1.1 Global Tumor Models Forecast by Regions (2024-2029)
    • 10.1.2 Americas Tumor Models Forecast
    • 10.1.3 APAC Tumor Models Forecast
    • 10.1.4 Europe Tumor Models Forecast
    • 10.1.5 Middle East & Africa Tumor Models Forecast
  • 10.2 Americas Tumor Models Forecast by Country (2024-2029)
    • 10.2.1 United States Tumor Models Market Forecast
    • 10.2.2 Canada Tumor Models Market Forecast
    • 10.2.3 Mexico Tumor Models Market Forecast
    • 10.2.4 Brazil Tumor Models Market Forecast
  • 10.3 APAC Tumor Models Forecast by Region (2024-2029)
    • 10.3.1 China Tumor Models Market Forecast
    • 10.3.2 Japan Tumor Models Market Forecast
    • 10.3.3 Korea Tumor Models Market Forecast
    • 10.3.4 Southeast Asia Tumor Models Market Forecast
    • 10.3.5 India Tumor Models Market Forecast
    • 10.3.6 Australia Tumor Models Market Forecast
  • 10.4 Europe Tumor Models Forecast by Country (2024-2029)
    • 10.4.1 Germany Tumor Models Market Forecast
    • 10.4.2 France Tumor Models Market Forecast
    • 10.4.3 UK Tumor Models Market Forecast
    • 10.4.4 Italy Tumor Models Market Forecast
    • 10.4.5 Russia Tumor Models Market Forecast
  • 10.5 Middle East & Africa Tumor Models Forecast by Region (2024-2029)
    • 10.5.1 Egypt Tumor Models Market Forecast
    • 10.5.2 South Africa Tumor Models Market Forecast
    • 10.5.3 Israel Tumor Models Market Forecast
    • 10.5.4 Turkey Tumor Models Market Forecast
    • 10.5.5 GCC Countries Tumor Models Market Forecast
  • 10.6 Global Tumor Models Forecast by Type (2024-2029)
  • 10.7 Global Tumor Models Forecast by Application (2024-2029)

11 Key Players Analysis

  • 11.1 Inotiv
    • 11.1.1 Inotiv Company Information
    • 11.1.2 Inotiv Tumor Models Product Offered
    • 11.1.3 Inotiv Tumor Models Revenue, Gross Margin and Market Share (2018-2023)
    • 11.1.4 Inotiv Main Business Overview
    • 11.1.5 Inotiv Latest Developments
  • 11.2 Charles River
    • 11.2.1 Charles River Company Information
    • 11.2.2 Charles River Tumor Models Product Offered
    • 11.2.3 Charles River Tumor Models Revenue, Gross Margin and Market Share (2018-2023)
    • 11.2.4 Charles River Main Business Overview
    • 11.2.5 Charles River Latest Developments
  • 11.3 WuXi Biology
    • 11.3.1 WuXi Biology Company Information
    • 11.3.2 WuXi Biology Tumor Models Product Offered
    • 11.3.3 WuXi Biology Tumor Models Revenue, Gross Margin and Market Share (2018-2023)
    • 11.3.4 WuXi Biology Main Business Overview
    • 11.3.5 WuXi Biology Latest Developments
  • 11.4 Labcorp
    • 11.4.1 Labcorp Company Information
    • 11.4.2 Labcorp Tumor Models Product Offered
    • 11.4.3 Labcorp Tumor Models Revenue, Gross Margin and Market Share (2018-2023)
    • 11.4.4 Labcorp Main Business Overview
    • 11.4.5 Labcorp Latest Developments
  • 11.5 IITRI
    • 11.5.1 IITRI Company Information
    • 11.5.2 IITRI Tumor Models Product Offered
    • 11.5.3 IITRI Tumor Models Revenue, Gross Margin and Market Share (2018-2023)
    • 11.5.4 IITRI Main Business Overview
    • 11.5.5 IITRI Latest Developments
  • 11.6 InSphero
    • 11.6.1 InSphero Company Information
    • 11.6.2 InSphero Tumor Models Product Offered
    • 11.6.3 InSphero Tumor Models Revenue, Gross Margin and Market Share (2018-2023)
    • 11.6.4 InSphero Main Business Overview
    • 11.6.5 InSphero Latest Developments
  • 11.7 Biomodels
    • 11.7.1 Biomodels Company Information
    • 11.7.2 Biomodels Tumor Models Product Offered
    • 11.7.3 Biomodels Tumor Models Revenue, Gross Margin and Market Share (2018-2023)
    • 11.7.4 Biomodels Main Business Overview
    • 11.7.5 Biomodels Latest Developments
  • 11.8 Reaction Biology
    • 11.8.1 Reaction Biology Company Information
    • 11.8.2 Reaction Biology Tumor Models Product Offered
    • 11.8.3 Reaction Biology Tumor Models Revenue, Gross Margin and Market Share (2018-2023)
    • 11.8.4 Reaction Biology Main Business Overview
    • 11.8.5 Reaction Biology Latest Developments
  • 11.9 Oncodesign Services
    • 11.9.1 Oncodesign Services Company Information
    • 11.9.2 Oncodesign Services Tumor Models Product Offered
    • 11.9.3 Oncodesign Services Tumor Models Revenue, Gross Margin and Market Share (2018-2023)
    • 11.9.4 Oncodesign Services Main Business Overview
    • 11.9.5 Oncodesign Services Latest Developments
  • 11.10 Creative Biolabs
    • 11.10.1 Creative Biolabs Company Information
    • 11.10.2 Creative Biolabs Tumor Models Product Offered
    • 11.10.3 Creative Biolabs Tumor Models Revenue, Gross Margin and Market Share (2018-2023)
    • 11.10.4 Creative Biolabs Main Business Overview
    • 11.10.5 Creative Biolabs Latest Developments
  • 11.11 Abnova
    • 11.11.1 Abnova Company Information
    • 11.11.2 Abnova Tumor Models Product Offered
    • 11.11.3 Abnova Tumor Models Revenue, Gross Margin and Market Share (2018-2023)
    • 11.11.4 Abnova Main Business Overview
    • 11.11.5 Abnova Latest Developments
  • 11.12 Invivocue
    • 11.12.1 Invivocue Company Information
    • 11.12.2 Invivocue Tumor Models Product Offered
    • 11.12.3 Invivocue Tumor Models Revenue, Gross Margin and Market Share (2018-2023)
    • 11.12.4 Invivocue Main Business Overview
    • 11.12.5 Invivocue Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Tumor Models. Industry analysis & Market Report on Tumor Models is a syndicated market report, published as Global Tumor Models Market Growth (Status and Outlook) 2023-2029. It is complete Research Study and Industry Analysis of Tumor Models market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,898.72
5,797.44
3,389.16
6,778.32
553,941.00
1,107,882.00
305,244.00
610,488.00
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report